Poussaint Tina Young, Vajapeyam Sridhar, Ricci Kelsey I, Panigrahy Ashok, Kocak Mehmet, Kun Larry E, Boyett James M, Pollack Ian F, Fouladi Maryam
Department of Radiology, Boston Children's Hospital, Boston, Massachusetts (T.Y.P., S.V., K.I.R.); Department of Radiology, Children's Hospital of Pittsburgh of the University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania (A.P.); Department of Diagnostic Imaging, St Jude Children's Research Hospital, Memphis, Tennessee (L.E.K.); Department of Biostatistics, St Jude Children's Research Hospital, Memphis, Tennessee (M.K., J.M.B.); Department of Neurosurgery, Children's Hospital of Pittsburgh, Pittsburgh, Pennsylvania (I.F.P.); Neuro-Oncology Program, Cincinnati Children's Hospital, Cincinnati, Ohio (M.F.).
Neuro Oncol. 2016 May;18(5):725-34. doi: 10.1093/neuonc/nov256. Epub 2015 Oct 20.
Diffuse intrinsic pontine glioma (DIPG) is associated with poor survival regardless of therapy. We used volumetric apparent diffusion coefficient (ADC) histogram metrics to determine associations with progression-free survival (PFS) and overall survival (OS) at baseline and after radiation therapy (RT).
Baseline and post-RT quantitative ADC histograms were generated from fluid-attenuated inversion recovery (FLAIR) images and enhancement regions of interest. Metrics assessed included number of peaks (ie, unimodal or bimodal), mean and median ADC, standard deviation, mode, skewness, and kurtosis.
Based on FLAIR images, the majority of tumors had unimodal peaks with significantly shorter average survival. Pre-RT FLAIR mean, mode, and median values were significantly associated with decreased risk of progression; higher pre-RT ADC values had longer PFS on average. Pre-RT FLAIR skewness and standard deviation were significantly associated with increased risk of progression; higher pre-RT FLAIR skewness and standard deviation had shorter PFS. Nonenhancing tumors at baseline showed higher ADC FLAIR mean values, lower kurtosis, and higher PFS. For enhancing tumors at baseline, bimodal enhancement histograms had much worse PFS and OS than unimodal cases and significantly lower mean peak values. Enhancement in tumors only after RT led to significantly shorter PFS and OS than in patients with baseline or no baseline enhancement.
ADC histogram metrics in DIPG demonstrate significant correlations between diffusion metrics and survival, with lower diffusion values (increased cellularity), increased skewness, and enhancement associated with shorter survival, requiring future investigations in large DIPG clinical trials.
弥漫性脑桥内在型胶质瘤(DIPG)无论采用何种治疗方法,其生存率均较低。我们使用体积表观扩散系数(ADC)直方图指标来确定其与基线及放射治疗(RT)后的无进展生存期(PFS)和总生存期(OS)之间的关联。
从液体衰减反转恢复(FLAIR)图像和感兴趣的强化区域生成基线和放疗后的定量ADC直方图。评估的指标包括峰数(即单峰或双峰)、平均和中位数ADC、标准差、众数、偏度和峰度。
基于FLAIR图像,大多数肿瘤为单峰,平均生存期明显较短。放疗前FLAIR的平均值、众数和中位数与进展风险降低显著相关;放疗前ADC值越高,平均PFS越长。放疗前FLAIR的偏度和标准差与进展风险增加显著相关;放疗前FLAIR偏度和标准差越高,PFS越短。基线时无强化的肿瘤显示出较高的ADC FLAIR平均值、较低的峰度和较高的PFS。对于基线时强化的肿瘤,双峰强化直方图的PFS和OS比单峰病例差得多,且平均峰值显著更低。仅在放疗后出现强化的肿瘤,其PFS和OS明显短于有基线强化或无基线强化的患者。
DIPG中的ADC直方图指标显示扩散指标与生存期之间存在显著相关性,扩散值较低(细胞密度增加)、偏度增加以及强化与生存期缩短相关,这需要在大型DIPG临床试验中进一步研究。